The diagnosis and treatment of Crohn's disease and ulcerative colitis.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 2695363)

Published in Dtsch Arztebl Int on February 20, 2009

Authors

Daniel C Baumgart1

Author Affiliations

1: Medizinische Klinik mit Schwerpunkt Gastroenterologie und Hepatologie, Charité, Campus Virchow Klinikum, Medizinische Fakultät der Humboldt Universität zu Berlin, Germany. daniel.baumgart@charite.de

Articles citing this

Pulmonary involvement in inflammatory bowel disease. World J Gastroenterol (2010) 0.87

Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review. Dig Dis Sci (2012) 0.85

TNF-alpha gene polymorphisms in Iranian Azari Turkish patients with inflammatory bowel diseases. Saudi J Gastroenterol (2014) 0.83

Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update. Clinics (Sao Paulo) (2010) 0.82

Ulcerative colitis in infancy. Saudi J Gastroenterol (2011) 0.80

Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire. Clin Exp Gastroenterol (2011) 0.78

Enhanced production of early lineages of monocytic and granulocytic cells in mice with colitis. Proc Natl Acad Sci U S A (2012) 0.78

The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study. Clin Exp Gastroenterol (2013) 0.78

Unexpected Regulatory Role of CCR9 in Regulatory T Cell Development. PLoS One (2015) 0.77

The Influence of Ghrelin on the Development of Dextran Sodium Sulfate-Induced Colitis in Rats. Biomed Res Int (2015) 0.76

Measuring patients' satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn's diseasE Questionnaire (SPACE-Q(©)). Patient Prefer Adherence (2014) 0.75

Clinical characterization of in vivo inflammatory bowel disease with Raman spectroscopy. Biomed Opt Express (2017) 0.75

Exogenous Ghrelin Accelerates the Healing of Acetic Acid-Induced Colitis in Rats. Int J Mol Sci (2016) 0.75

Synergic Interaction of Rifaximin and Mutaflor (Escherichia coli Nissle 1917) in the Treatment of Acetic Acid-Induced Colitis in Rats. Gastroenterol Res Pract (2016) 0.75

Intestinal inflammation without weight loss decreases bone density and growth. Am J Physiol Regul Integr Comp Physiol (2016) 0.75

[Genius between music and disease : Medical considerations on Ludwig van Beethoven]. Wien Med Wochenschr (2015) 0.75

Articles cited by this

Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA (2006) 15.65

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet (2008) 10.47

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16

Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet (2007) 7.81

Inflammatory bowel disease: cause and immunobiology. Lancet (2007) 6.07

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology (2006) 3.68

European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57

Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology (2008) 3.52

Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis (2005) 3.01

Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88

Clinical practice. Acute infectious diarrhea. N Engl J Med (2004) 2.47

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology (2002) 2.15

European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology (2006) 1.78

European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis (2008) 1.34

[Clinical practice guideline on diagnosis and treatment of Crohn's disease]. Z Gastroenterol (2008) 1.19

American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology (2006) 1.06

Current concepts and controversies in surgery for IBD. Gastroenterology (2004) 1.02

[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]. Z Gastroenterol (2004) 0.97

Acute surgical emergencies in inflammatory bowel disease. Am J Surg (2002) 0.94